<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Vuerich M</submitter><funding>NIDDK NIH HHS</funding><pagination>1429736</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11345147</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>12</volume><pubmed_abstract>Extracellular ATP and its derivates mediate a signaling pathway that might be pharmacologically targeted to treat inflammatory conditions. Extracellular adenosine, the product of ATP hydrolysis by ectonucleotidase enzymes, plays a key role in halting inflammation while promoting immune tolerance. The rate-limiting ectoenzyme ENTPD1/CD39 and the ecto-5'-nucleotidase/CD73 are the prototype members of the ectonucleotidase family, being responsible for ATP degradation into immunosuppressive adenosine. The biological effects of adenosine are mediated via adenosine receptors, a family of G protein-coupled receptors largely expressed on immune cells where they modulate innate and adaptive immune responses. Inflammatory bowel disease (IBD) is a serious inflammatory condition of the gastrointestina</pubmed_abstract><journal>Frontiers in cell and developmental biology</journal><pubmed_title>Adenosine-mediated immune responses in inflammatory bowel disease.</pubmed_title><pmcid>PMC11345147</pmcid><funding_grant_id>R01 DK124408</funding_grant_id><pubmed_authors>Longhi MS</pubmed_authors><pubmed_authors>Vuerich M</pubmed_authors><pubmed_authors>Ferrari D</pubmed_authors><pubmed_authors>Nguyen DH</pubmed_authors></additional><is_claimable>false</is_claimable><name>Adenosine-mediated immune responses in inflammatory bowel disease.</name><description>Extracellular ATP and its derivates mediate a signaling pathway that might be pharmacologically targeted to treat inflammatory conditions. Extracellular adenosine, the product of ATP hydrolysis by ectonucleotidase enzymes, plays a key role in halting inflammation while promoting immune tolerance. The rate-limiting ectoenzyme ENTPD1/CD39 and the ecto-5'-nucleotidase/CD73 are the prototype members of the ectonucleotidase family, being responsible for ATP degradation into immunosuppressive adenosine. The biological effects of adenosine are mediated via adenosine receptors, a family of G protein-coupled receptors largely expressed on immune cells where they modulate innate and adaptive immune responses. Inflammatory bowel disease (IBD) is a serious inflammatory condition of the gastrointestina</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024</publication><modification>2025-04-18T16:52:54.044Z</modification><creation>2025-04-07T04:19:25.992Z</creation></dates><accession>S-EPMC11345147</accession><cross_references><pubmed>39188525</pubmed><doi>10.3389/fcell.2024.1429736</doi></cross_references></HashMap>